Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Lilly has a new pill, called orforglipron, it plans to launch next year. On Thursday, the company reported the results of a ...

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

Obesity is not a single disease. New research shows distinct biological phenotypes that explain why weight gain and treatment ...

A 6-month fully remote weight-loss program tailored to veterans with serious mental illness yielded numerically greater ...

An advert which targeted weight-loss injections at new mums has been banned by the Advertising Standards Authority (ASA). MedExpress's social media post used a harmful gender stereotype which ...

By taking into account a patient’s unique biology, psychology, environment and behaviors, Hims & Hers is able to offer access ...

The implications from the design of the clinical GLP-1 agonist trials and studies of caloric restriction are that exercise is ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental weight‑loss pill, after the company pushed for a faster ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...